Editorial: tofacitinib post-marketing safety reports among ulcerative colitis patients.

Authors	Ido Veisman, Shomron Ben-Horin
Journal	Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 55 Issue 1 Pg. 131-132 (01 2022) ISSN: 1365-2036 [Electronic] England
PMID	34907564 (Publication Type: Editorial, Comment)
Chemical References	Piperidines Pyrimidines tofacitinib
Topics	Colitis, Ulcerative (drug therapy) Humans Marketing Piperidines (adverse effects) Pyrimidines (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!